Jump to content

Oskar Fischer

From Wikipedia, the free encyclopedia
For people with the same name, see Oskar Fischer (disambiguation).

Oskar Fischer
Portrait c. 1930s
Born12 April 1876
Slaný, Bohemia
Died28 February 1942(1942-02-28) (aged 65)
Terezin, Czechoslovakia
NationalityCzech
Alma mater
Medical career
ProfessionDoctor
Field
InstitutionsGerman University in Prague
Research
  • Dementia
  • Alzheimer disease

Oskar Fischer (12 April 1876 – 28 February 1942) was a Czech academic, psychiatrist and neuropathologist whose studies on dementia and Alzheimer's disease were rediscovered in 2008.

Early life and education

[edit]

Fischer was born into a German-speaking Jewish family in Slaný in central Bohemia, 25 km northwest of Prague, on 12 April 1876.[1][2][3] His father was the manager of an agricultural estate there. He completed primary and secondary education in Slaný. Then he attended the medical schools of both Prague University and Strasbourg University, and graduated from Prague University in 1900.[1]

Career

[edit]

Fischer began his career at the department of pathological anatomy of German University in 1900. Next, he joined the department of psychiatry of the same university in 1902, and worked there until 1919.[1] Fischer served as a physician-in-chief at the division of neurology and psychiatry of the second garrison hospital in Prague during World War I, and treated many soldiers who had experienced mental difficulties while fighting on the Eastern Front. After challenging and criticising German medical doctor Halbhuber, his chief at the division, Fischer was transferred to barracks hospital in Pardubice in eastern Bohemia and served there until the end of the war.[1] In Pardubice, he met Franziska, his prospective wife, working as a voluntary nurse with the Red Cross. Later, they had two children, the twins Lotte and Heinz.[1] Fischer left his tenure at the German University in 1939 and opened a private office for neurology and psychiatry in Prague where he worked until 1941.[1]

Studies on Alzheimer's disease

[edit]

Fischer was a member of the Prague neuropathological school headed by Arnold Pick during his studies in German University.[4] This school was one of the two neuropathological schools (the other one was in Munich headed by Emil Kraepelin where Alois Alzheimer worked) framed Alzheimer's disease through empirical discoveries.[5] In fact, these schools were rivals, leading to the designation of the disease as "Alzheimer's disease"[6] in the Emil Kraepelin's book entitled Psychiatry (1910).[7] Because the inclusion of this disease with Alzheimer's name in the book made the Munich school superior over the Prague school.[8][9]

Fischer supposedly (like Alois Alzheimer) employed new staining and autopsy results, and described "senile plaques" that are still accepted as the characteristic of the disease in addition to "neurofibrillary tangles" discovered by Alzheimer.[5] Both Fischer and Alzheimer argued that senile plaques may be formed by microorganisms.[10] In June 1907, based on the reports of Beljahow that had been later affirmed by Redlich and Leri Fischer argued that 'miliary necrosis' should be regarded as a marker of senile dementia.[11] Then he published an article in 1907, reporting histopathological findings on senile dementia collected from a sample of 16 postmortem brains from elderly subjects.[12] The report described the brain changes at tissual and cellular levels.[8] He developed a comprehensive structural analysis about the changes involving amyloid aggregates observed in the samples.[13] He named these lesions as "Sphaerotrichia cerebri multiplex" and used this term in his subsequent articles published in 1910 and 1912. The samples of his studies included 58 positive cases out of total 275 cases.[13] Fischer's disease (Sphaerotrichia cerebri multiplex) was mainly characterized clinically by presbyophrenia [14] and pathologically by neuritic plaques.[15] Ultimately, both Alzheimer and Fischer agreed on the uniqueness of a new clinicopathological condition, regardless of the age of onset[15]. This condition encompassed a portion of Kraepelin's senile dementia. However, they disagreed on both the clinical and pathological features, especially on the relative significance of neurofibrillary tangles versus neuritic plaques[15].

Rediscovery of his studies on Alzheimer's disease

[edit]

Although Fischer extensively studied and made significant contributions to the identification and description of Alzheimer's disease, his contributions were remained unknown for a long time and recognised through the studies carried out in the historical archives in Prague.[16] On the other hand, although N. C. Berchtold and C. W. Cotman of the University of California at Irvine College of Medicine reported Fischer's research on the disease and the competition between the two medical schools in 1998,[6] Fischer's studies did not become locus of interest until 2008. Michel Goedert of the MRC laboratory of molecular biology at Cambridge University uncovered Fischer's significance after his study in the archives of Charles University in Prague in 2008. He also interviewed Fischer's relatives and Czech researchers studying on the disease.[16] Pavel Kalvach of the Charles University of Prague pointed out in 2009 that Fischer made arguably even much more important contributions than Alois Alzheimer to the description of the disease.[16][17] The reasons for neglecting Fischer's contributions included the nationalist tensions and the anti-Semitic approach of his period[16] as well as the academic competition between the Prague and Munich neuropathology schools.[9]

Arrest by Gestapo and death

[edit]

Nearly three years after the German occupation of Czechoslovakia, Fischer was arrested by the Gestapo in 1941. He was detained in small fortress in Terezin (Theresienstadt) in northwestern Bohemia, which was set up near Prague.[18] He died at the age of 65 in the camp on 28 February 1942 after being beaten to death.[1][19]

References

[edit]
  1. ^ a b c d e f g Michel Goedert (2009). "Oskar Fischer and the study of dementia" (Occasional Papers). Brain. 132 (4): 1102–1111. doi:10.1093/brain/awn256. PMC 2668940. PMID 18952676.
  2. ^ "Prague: What Say You, Alois—Should It Be "Alzheimer-Fischer" Disease?". Alzheimer Forum. 20 March 2009. Retrieved 4 September 2012.
  3. ^ "Rewriting the Book on Alzheimer's Disease: Alumni Magazine Summer 2018". College of Medicine. Summer 2018. Retrieved 26 August 2023.
  4. ^ Philip C. Wong; et al. (2011). "Neurobiology of Alzheimer's disease". In Scott T. Brady; et al. (eds.). Basic Neurochemistry: Principles of Molecular, Cellular, and Medical Neurobiology. Waltham, MA: Academic Press. p. 828. ISBN 978-0-08-095901-6.
  5. ^ a b Annemarie Goldstein Jutel (2011). Putting a Name to It: Diagnosis in Contemporary Society. Baltimore, MD: The JHU Press. p. 92. ISBN 978-1-4214-0067-9.
  6. ^ a b N. C. Berchtold; C. W. Cotman (May–June 1998). "Evolution in the Conceptualization of Dementia and Alzheimer's Disease: Greco-Roman Period to the 1960s". Neurobiology of Aging. 19 (3): 173–189. doi:10.1016/s0197-4580(98)00052-9. PMID 9661992. S2CID 24808582.
  7. ^ N. Zilka; M. Novak (2006). "The tangled story of Alois Alzheimer". Bratisl Lek Listy. 107 (9–10): 343–345. PMID 17262985.
  8. ^ a b H.-J. Möller; M. B. Graeber (1998). "The case described by Alois Alzheimer in 1911". European Archives of Psychiatry and Clinical Neuroscience. 248 (3): 111–122. doi:10.1007/s004060050027. PMID 9728729. S2CID 22834261.
  9. ^ a b Matthias M. Weber (1997). "Aloys Alzheimer, a Coworker of Emil Kraepelin". Journal of Psychiatric Research. 31 (6): 635–645. doi:10.1016/s0022-3956(97)00035-6. PMID 9447568.
  10. ^ Judith Miklossy (2011). "Alzheimer's disease – a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria". Journal of Neuroinflammation. 8 (90): 1–16. doi:10.1186/1742-2094-8-90. PMC 3171359. PMID 21816039.
  11. ^ "The markers of the new disease". Alzheimer ADNA. 23 June 2006. Archived from the original on 22 November 2008. Retrieved 4 September 2012.
  12. ^ Karthikeyan Balakrishnan (2013). Alzheimer's disease: Amyloid oligomers, therapeutic agents, their targets, and mode of action (PhD thesis). Philipps-Universität Marburg.
  13. ^ a b Pavel Kalvach; Zdeněk Kalvach. "History of understanding dementia" (PDF). ICMHP. Archived from the original (PDF) on 18 October 2011. Retrieved 4 September 2012.
  14. ^ Berrios, G. E. (May 1986). "Presbyophrenia: the rise and fall of a concept". Psychological Medicine. 16 (2): 267–275. doi:10.1017/S0033291700009089. ISSN 1469-8978.
  15. ^ a b c Villain, Nicolas; Michalon, Robin (November 2024). "What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries". European Journal of Neurology. 31 (11). doi:10.1111/ene.16302. ISSN 1351-5101. PMC 11464395. PMID 38618742.
  16. ^ a b c d "Remembering A Forgotten Co-discoverer of Alzheimer Disease". Medical News Today. 10 April 2009. Retrieved 3 September 2012.
  17. ^ "Why the name Alzheimer's disease?". Fragen und antworten. Retrieved 4 September 2012.
  18. ^ "Remembering a Forgotten Co-discoverer of Alzheimer Disease". Armenian Health Network. 13 April 2009. Retrieved 28 January 2013.
  19. ^ Vladimir VonDracek (1977). Lekar Dale Vzpomina. Prague: Avicenum. pp. 195–196.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Oskar_Fischer&oldid=1256563981"